NCT01166672

Completed

BCRL Prevention Pilot

Abramson Cancer Center at Penn Medicine Source

Compare

Other study identifiers

Sponsor study identifier

UPCC 15110

Study Type

observational

Estimated enrollment

20

Locations

1 country

Sites

1

Timeline

Study Start

July 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

October 2012

Actual (reported)

Study Completion

October 2012

Actual (reported)

Brief Summary

The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 months.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Estimated enrollment: 20 participants
Study completion date: October 2012
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2010
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 20, 2010
Actual (reported)
First Posted
July 21, 2010
Actual (reported)
Primary Completion
October 2012
Actual (reported)
Study Completion
October 2012
Actual (reported)

Last Updated: October 12, 2012
Status Verified: October 2012
Last Update Submitted: October 11, 2012

Conditions

Breast Cancer Obesity

Keywords

obese women (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are donewith surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within thepast 2 years will be invited to participate.

Outcome Measures

Primary Outcomes (1)

Follow-up Appts.
The primary outcome will be the precent of participants who complete 6 month follow-up appointments.
6 months

Secondary Outcomes (1)

Response Rates
6 months

Eligibility Criteria

Age18 Years - 70 Years

Sexfemale

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodProbability Sample

Study Population

Women, aged 18-70, who are obese (BMI greater than or equal to 30), do not already have a diagnosis of lymphedema, who are done with surgery, chemotherapy, and radiation therapy, and who were diagnosed with breast cancer within the past 2 years will be invited to participate.

You may qualify if:

Women

Sponsors & Collaborators

Abramson Cancer Center at Penn Medicine
Otherlead

Study Sites (1)

Abramson Cancer Center of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

MeSH Terms

Conditions

ObesityBreast Neoplasms

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type: observational
Observational Model: COHORT
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 20, 2010

First Posted

July 21, 2010

Study Start

July 2010

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

October 2012

Actual (reported)

NCT01537029

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

Phase 4Completed

NCT01793948

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

Early Phase 1Completed

NCT02255240

LEVEL UP: Video Games for Activity in Breast Cancer Survivors

Not ApplicableWithdrawn

NCT02152462

Exergaming Intervention and Breast Cancer Biomarkers in Black Women

Phase 2Completed

NCT00343434

Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight

Not ApplicableCompleted

NCT07101861

Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study

Not ApplicableCompleted

Breast Cancer Survivors who had 5 or more lymph nodes removed and radiation to lymph nodes as part of treatment.

Completed all treatments - no metastatic cancers

Overweight or obese (BMI greater than or equal to 25 kg/m2)

Medically and logistically able to participate in a weight loss and exercise program over 6 months.

Diagnosed with breast cancer within the past 2 years.

You may not qualify if:

More than 2 years since breast cancer diagnosis
Medical status that would preclude safety of participation in a weight loss and exercise program
Metastatic cancer
Already enrolled in a weight loss program

Contact the study team to confirm eligibility.

Study Completion

October 2012

Actual (reported)

Last Updated

October 12, 2012

Record last verified: 2012-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT01166672
Data provider: ClinicalTrials.gov
Source updated: 2012-10-12
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:32:25 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations